Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249389 | SCV000311663 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000249389 | SCV000860121 | benign | not specified | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001522264 | SCV001731778 | benign | Familial hemophagocytic lymphohistiocytosis 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610679 | SCV001841043 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001522264 | SCV002062138 | benign | Familial hemophagocytic lymphohistiocytosis 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000249389 | SCV004101932 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 70% of patients studied by a panel of primary immunodeficiencies. Number of patients: 67. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001610679 | SCV005313179 | benign | not provided | criteria provided, single submitter | not provided |